COVID-19 in patients with sickle cell disease: A single center experience from Ohio, United States.
作者信息
Sahu Kamal Kant, George Laeth, Jones Nelroy, Mangla Ankit
机构信息
Saint Vincent Hospital, Worcester, Massachusetts, USA.
Department of Internal Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
出版信息
J Med Virol. 2021 May;93(5):2591-2594. doi: 10.1002/jmv.26816. Epub 2021 Feb 1.
Abstract
摘要
相似文献
1
COVID-19 in patients with sickle cell disease: A single center experience from Ohio, United States.镰状细胞病患者中的新冠病毒疾病：来自美国俄亥俄州的单中心经验
J Med Virol. 2021 May;93(5):2591-2594. doi: 10.1002/jmv.26816. Epub 2021 Feb 1.
2
Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study.镰状细胞疾病与严重新型冠状病毒肺炎结局：一项队列研究
Ann Intern Med. 2021 Oct;174(10):1483-1487. doi: 10.7326/M21-1375. Epub 2021 Jul 20.
3
The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey.新冠疫情对东伦敦镰状细胞患者群体的实际影响：一项全服务范围调查的结果
Br J Haematol. 2021 Nov;195(4):532-535. doi: 10.1111/bjh.17740. Epub 2021 Sep 14.
4
Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.比较镰状细胞病患者与医护人员 COVID-19 感染的临床病程。
Ann Hematol. 2021 Sep;100(9):2195-2202. doi: 10.1007/s00277-021-04549-1. Epub 2021 May 25.
5
A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.一项针对28名患有镰状细胞病和新冠肺炎的孕妇的研究：孕产妇和胎儿发病率升高。
Haematologica. 2024 May 1;109(5):1562-1565. doi: 10.3324/haematol.2023.283300.
6
COVID-19 infection and sickle cell disease: a UK centre experience.新型冠状病毒肺炎感染与镰状细胞病：英国一家中心的经验
Br J Haematol. 2020 Jul;190(2):e57-e58. doi: 10.1111/bjh.16779. Epub 2020 Jun 17.
7
Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report.镰状细胞病成人患者合并急性呼吸窘迫综合征的严重 COVID-19：病例报告。
BMC Pulm Med. 2021 Jan 29;21(1):46. doi: 10.1186/s12890-021-01412-x.
8
COVID-19 and sickle cell disease in Bahrain.巴林的 COVID-19 和镰状细胞病。
Int J Infect Dis. 2020 Dec;101:14-16. doi: 10.1016/j.ijid.2020.09.1433. Epub 2020 Sep 24.
9
Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.新型冠状病毒肺炎感染对24例镰状细胞病患者的影响。美国密歇根州底特律市一家中心的城市经验。
Hemoglobin. 2020 Jul;44(4):284-289. doi: 10.1080/03630269.2020.1797775. Epub 2020 Jul 28.
10
Simultaneous diagnosis of severe SARS-CoV-2 infection and sickle cell disease in two infants.两名婴儿同时被诊断出患有严重的SARS-CoV-2感染和镰状细胞病。
Blood Transfus. 2021 Mar;19(2):120-123. doi: 10.2450/2021.0430-20. Epub 2021 Feb 3.
引用本文的文献
1
Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review.2019冠状病毒病感染对镰状细胞病患者的影响：一项综合综述。
Front Med (Lausanne). 2023 May 2;10:1144226. doi: 10.3389/fmed.2023.1144226. eCollection 2023.
2
Examining resilience of individuals living with sickle cell disease in the COVID-19 pandemic.探讨 COVID-19 大流行期间镰状细胞病患者的韧性。
BMC Psychol. 2022 Jun 20;10(1):156. doi: 10.1186/s40359-022-00862-0.
3
Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.镰状细胞病和镰状细胞性状患者感染新型冠状病毒肺炎的临床结局：文献的批判性评价
Blood Rev. 2022 May;53:100911. doi: 10.1016/j.blre.2021.100911. Epub 2021 Nov 20.
4
COVID-19 Vaccines Programs: adverse events following immunization (AEFI) among medical Clerkship Student in Jember, Indonesia.COVID-19 疫苗计划：印度尼西亚井里汶医学实习学生中的疫苗接种后不良反应（AEFI）。
BMC Pharmacol Toxicol. 2021 Oct 12;22(1):58. doi: 10.1186/s40360-021-00528-4.
5
Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients.脂质代谢的改变为无症状和有症状 COVID-19 患者的检测提供了血清学生物标志物。
Sci Rep. 2021 Jul 9;11(1):14232. doi: 10.1038/s41598-021-93857-7.
6
COVID-19 Mortality in a Pediatric Patient with Hemoglobin SC Disease and Alpha-Thalassemia Trait.一名患有血红蛋白SC病和α地中海贫血特征的儿科患者的COVID-19死亡率
Case Rep Crit Care. 2021 Apr 27;2021:6617362. doi: 10.1155/2021/6617362. eCollection 2021.
本文引用的文献
1
COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.镰状细胞病患者的新型冠状病毒肺炎——来自英国一家三级医院的病例系列
Haematologica. 2020 Nov 1;105(11):2691-2693. doi: 10.3324/haematol.2020.254250.
2
Current perspective on pandemic of COVID-19 in the United States.美国新冠肺炎疫情的当前视角。
J Family Med Prim Care. 2020 Apr 30;9(4):1784-1791. doi: 10.4103/jfmpc.jfmpc_424_20. eCollection 2020 Apr.
3
Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020.2020 年 3 月 20 日至 5 月 21 日美国镰状细胞病患者中的冠状病毒病。
Emerg Infect Dis. 2020 Oct;26(10):2473-2476. doi: 10.3201/eid2610.202792. Epub 2020 Jul 8.
4
Prognosis of patients with sickle cell disease and COVID-19: a French experience.镰状细胞病患者与新冠病毒病的预后：法国的经验
Lancet Haematol. 2020 Sep;7(9):e632-e634. doi: 10.1016/S2352-3026(20)30204-0. Epub 2020 Jun 18.
5
Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.管理新冠病毒感染的镰状细胞病患者：汇聚我们集体经验的必要性。
Br J Haematol. 2020 Jul;190(2):e86-e89. doi: 10.1111/bjh.16880. Epub 2020 Jun 11.
6
COVID-19 infection and sickle cell disease: a UK centre experience.新型冠状病毒肺炎感染与镰状细胞病：英国一家中心的经验
Br J Haematol. 2020 Jul;190(2):e57-e58. doi: 10.1111/bjh.16779. Epub 2020 Jun 17.
7
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China.中国武汉 69 例 2019 年冠状病毒病患者的临床特征。
Clin Infect Dis. 2020 Jul 28;71(15):769-777. doi: 10.1093/cid/ciaa272.
Zotero 插件